Company Coegin Pharma AB

Equities

COEGIN

SE0020357754

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 03:30:00 10/06/2024 am IST 5-day change 1st Jan Change
5.96 SEK -2.93% Intraday chart for Coegin Pharma AB +1.36% +10.68%

Business Summary

Coegin Pharma AB, formerly GoldBlue AB (publ) is a Sweden-based biotechnology company. The Company focuses on the development of small molecule therapies aimed at the key enzyme, which is known for its involvement in a variety of inflammatory diseases as well as in cancer. Coegin Pharma AB provides consulting and management services in drug development as well.

Number of employees: 3

Managers

Managers TitleAgeSince
Director of Finance/CFO 49 01/22/01
Chief Tech/Sci/R&D Officer 66 01/05/01
Sales & Marketing 47 01/22/01
Corporate Officer/Principal 54 01/21/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 01/20/01
Director/Board Member 66 01/22/01
Director/Board Member 62 01/23/01
Chairman 49 01/23/01
62 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,961,467 5,591,322 ( 35.03 %) 0 35.03 %

Company contact information

Coegin Pharma AB

Mediacon Village

223 81, Lund

+

http://www.coeginpharma.com
address Coegin Pharma AB(COEGIN)
  1. Stock Market
  2. Equities
  3. COEGIN Stock
  4. Company Coegin Pharma AB